Patents by Inventor Stephen K. Murphy

Stephen K. Murphy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PYRROLIDIONE DERIVATIVES AS INHIBITORS OF NF KAPPA B INDUCING KINASE
    Publication number: 20250304567
    Abstract: The present disclosure relates to compounds of Formula (I) that inhibit NIK and pharmaceutical compositions comprising such compounds and methods of using the same. These compounds and pharmaceutical compositions are useful for preventing or treating diseases such as but not limited to inflammatory disorders and autoimmune disorders.
    Type: Application
    Filed: May 10, 2023
    Publication date: October 2, 2025
    Applicant: Janssen Pharmaceutica NV
    Inventors: Stephen K. Murphy, Alexander R. Rovira, Alexander J. Maertens, Alex D. Lebsack, Ronald L. Wolin, Wenying Chai, Anastassia Matviitsuk
  • PYRROLIDINONE DERIVATIVES AS INHIBITORS OF NF KAPPA B INDUCING KINASE
    Publication number: 20250282768
    Abstract: The present disclosure relates to compounds of Formula (I?) that inhibit NIK and pharmaceutical compositions comprising such compounds and methods of using the same. These compounds and pharmaceutical compositions are useful for preventing or treating diseases such as inflammatory disorders and autoimmune disorders.
    Type: Application
    Filed: May 10, 2023
    Publication date: September 11, 2025
    Applicant: Janssen Pharmaceutica NV
    Inventors: Alexander R. Rovira, Stephen K. Murphy, Alec D. Lebsack, Wenying Chai, Daniel Enny, Alexander Maertens, Michael Ameriks
  • PYRROLIDINONE DERIVATIVES AS INHIBITORS OF NF KAPPA B INDUCING KINASE
    Publication number: 20250282785
    Abstract: The present disclosure relates to compounds of Formula (I) that inhibit NIK and pharmaceutical compositions comprising such compounds and methods of using the same. These compounds and pharmaceutical compositions are useful for preventing or treating diseases such as inflammatory disorders and autoimmune disorders.
    Type: Application
    Filed: May 10, 2023
    Publication date: September 11, 2025
    Applicant: Janssen Pharmaceutica NV
    Inventors: Marc Adler, Wenying Chai, Wendy Eccles, Kevin Greenman, Michael D. Hack, William M. Jones, Paul J. Krawczuk, Alec D. Lebsack, Ronald L. Wolin, Stephen K. Murphy, Alexander R. Rovira
  • New Pleuromutilin Antibiotic Compounds, Compositions and Methods of Use and Synthesis
    Publication number: 20190352262
    Abstract: The present invention is directed to novel pleuroniutilin antibiotic compounds, intermediates which are useful for making these novel amibioiic compounds and related methods and pharmaceutical compositions for treating pathogens, especially bacterial infections, including gram negative bacteria and synthesizing these compounds.
    Type: Application
    Filed: February 1, 2018
    Publication date: November 21, 2019
    Inventors: Seth Herzon, Stephen K. Murphy, Mingshuo Zeng